about
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wastingCrosstalk between the heart and peripheral organs in heart failureTyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Gene expression, function and ischemia tolerance in male and female rat hearts after sub-toxic levels of angiotensin II.Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexiaCardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease.New and emerging biomarkers of heart failure.Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism.Congestive heart failure: where homeostasis begets dyshomeostasis.Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.
P2860
Q24609841-E0740A38-5332-4A20-9826-ED6CA8655B0EQ26766491-D7D628CA-B218-4D97-87D0-EE1810DB490CQ34022338-6A7853BA-0F6B-45BF-AF3D-92DDCB642C86Q34061092-2A1ADF78-17A3-4D7A-8742-54D4806CE5CAQ34561377-B924C009-C47F-4409-B948-DB8BDA491DE7Q35110459-9F3B8E55-17ED-47E7-A6A4-E4596620004CQ35762656-A8469A5A-3B17-4BA6-92E9-217DB4F623E6Q36707757-5988B537-C308-489B-BC0C-CDB765B5728CQ37076096-4B767D21-E2CD-4712-B92A-CBBFCC9AC37DQ37451582-AD8CE184-7751-4418-BCF4-52CEE1FFE2FEQ37514230-2FC96592-088E-45BF-860B-A260E7905A9AQ40026105-2068DC64-76D9-4FC1-9BC4-2AF39B03D236Q42425309-F6BACF5E-18C1-4BF5-A9D6-E7005BC58020Q42554473-F76E47B2-90BB-422A-8C21-B238BB327D9CQ47851502-825A0397-EBDD-41B8-BCDC-EF5B04ECEB1AQ54189352-2BE98CD4-1C94-433E-AEC0-BCBDE59ECF62Q55383187-7D18F4AE-A7BB-4CBF-B376-1EF42A25FEE5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Angiotensin II as candidate of cardiac cachexia
@ast
Angiotensin II as candidate of cardiac cachexia
@en
type
label
Angiotensin II as candidate of cardiac cachexia
@ast
Angiotensin II as candidate of cardiac cachexia
@en
prefLabel
Angiotensin II as candidate of cardiac cachexia
@ast
Angiotensin II as candidate of cardiac cachexia
@en
P2860
P1476
Angiotensin II as candidate of cardiac cachexia
@en
P2093
Makoto Akao
P2860
P304
P356
10.1097/01.MCO.0000222103.29009.70
P577
2006-05-01T00:00:00Z